LifeVantage (NASDAQ:LFVN – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, October 29th. LifeVantage has set its FY 2025 guidance at 0.700-0.800 EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.
LifeVantage (NASDAQ:LFVN – Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a return on equity of 27.85% and a net margin of 1.47%. The company had revenue of $48.93 million during the quarter.
LifeVantage Stock Up 8.6 %
Shares of NASDAQ LFVN opened at $14.09 on Monday. LifeVantage has a 52 week low of $4.20 and a 52 week high of $14.71. The business has a 50-day simple moving average of $10.58 and a two-hundred day simple moving average of $8.20. The company has a market cap of $175.84 million, a P/E ratio of 61.26 and a beta of 0.84.
LifeVantage Dividend Announcement
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
- Five stocks we like better than LifeVantage
- What is the S&P/TSX Index?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Why Invest in 5G? How to Invest in 5G Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.